夜明颗粒对视网膜色素变性小鼠感光细胞保护作用的研究
|
摘要
视网膜色素变性(RP)是一种遗传性视网膜变性疾病,本文从理论、实验二个方面对治疗视网膜色素变性的自拟益气补肾活血方“夜明颗粒”进行了研究。
RP发病具有遗传倾向,因先天不足,肝肾亏虚,致脾肾阳虚,命门火衰,使气血不利,目络瘀阻而致。这一过程是一个以虚为本,因虚致瘀,最终发展为虚中夹瘀的缓慢病理过程。在此认识的基础上,导师丁淑华教授根据自己多年临床经验,针对其发病机理,以补益肝肾、益气活血、化瘀通络为法,自拟单味中药浓缩颗粒配方夜明颗粒治疗RP。
临床上观察夜明颗粒治疗RP患者,对治疗后患者视力、视敏度、闪光视网膜电图进行分析,所得临床资料表明夜明颗粒在治疗RP和减缓病情发展方面有一定的疗效,各项指标均有不同程度的改善,有效率达84.5%。
前期的动物实验是通过观察、分析夜明颗粒不同剂量对小鼠微循环、清除体内自由基、调节免疫,对大鼠血液流变学影响等7个实验的结果来探讨夜明颗粒制剂治疗RP的机理。实验数据表明夜明颗粒可以改善微循环,降低血黏度,具有活血化瘀作用;改善小鼠血液SOD活性,降低MDA值,增强小鼠清除体内自由基和积存的脂质过氧化物的能力;对免疫功能有调节作用。
为了进一步探讨夜明颗粒制剂对RP的疗效机制,我们通过观察rds小鼠视网膜光感受器细胞的病理变化来探讨夜明颗粒对遗传性视网膜色素变性小鼠可能的治疗作用。取4周龄、12周龄、24周龄rds鼠各9只,都随机分为三组,夜明颗粒组4只、杞菊地黄丸组3只和对照组2只。给药28d后取眼球,立即经10%中性甲醛固定,光学显微镜下观察水平视网膜近赤道部位光感受器细胞的厚度。经夜明颗粒治疗后,光镜结果显示,rds小鼠光感受器细胞层数、细胞数明显增加及光感受器细胞凋亡率的下降(P＜0.05)。实验的结果表明夜明颗粒可延缓rds小鼠视网膜感受器细胞的破坏。
Retinitis pigmentosa(RP) is a hereditary retinal degenerative disease. This paper researches treating the RP with "Yeming grain" from three aspects which are the theory studying,the clinical research and the empirical study, as well as explores the possible mechanism of the qi and kidney tonics and blood-activating and stasis-removing drugs "Yeming grain" treating the RP.
The morbility of the RP possesses genetic predisposition. The cause is inherent deficiency,deficiency of the liver and kidney,which results in asdthenic splenonephro-yang,decline of vital gate-fire,qi and blood disorder,eye collaterals stagnation. This is a slow-moving patho- process which is based on void, then results in stagnation,and develops to void nipping stagnation at last. My tutor Shuhua Ding invents the prescription of "Yeming grain" to treat the RP according to her clinical experience. This prescription aims directly at the etiopathogenesis of the RP,and establishes the principle of removing stagnation and filling void.
The clinical observation of the patient who is treated by "Yeming grain" and the analyses of eyesight, visual acuity,and bright-flash electroretinogram indicate that "Yeming grain" is effective."Yeming grain" can not only relieve the progression of disease but improve each index. The effective rate is 84.5%.
In the first text,we give the treatment to rats,then observe and analyze the effect of different dosages on the microcirculation,cleaning up the free radicle in vivo,accommodating the immunity and the rat's hemorheology.Results:"Yeming grain" can improve the microcirculation,step down the blood viscosity, promote blood flow and remove stagnation;it can improve the SOD activity of rat's blood,step down the value of MDA,and enhance the cat's capability of cleaning up the free radicle in vivo and the accumulation of lipid peroxidate;it also have accommodative effect on the immune function.
To go deep into exploring the mechanism of "Yeming grain" treating the RP and to determine whether tetram ethylpyrazine hydrochlorde has an efficacy on hereditary retinitis pigmentosa of rds mice by the observation of the photo receptor cells. Nine rds mice of 4 week old were randomly divided into three groups, "Yeming grain" group(4 mice),"qujudihuangwan" group(3 mice) and control group(2 mice).All mice were sacrificed after 28d with eyes being immediately enucleated and fixed in 10% form aldehyde in PBS. Routine pathologic process was done and sections were stained by hematoxylin and eosin(HE).The layer numbers of retinal photo receptor cells at equator posterior center was counted under light micro scopy. Nine rds mice of 12week old did as so on.
Result from light microscopy showed that the layer numbers and numbers of retinal photo receptor cells in the tetram ethylpyrazine treatment group were increased in rds mice,compared with the control group(P<0.05).
Conclusion from light microscopy and electron microscope suggest that tetram ethylpyrazine has a significant efficacy to the retinal photo receptor cells of rds mice.
RP发病具有遗传倾向,因先天不足,肝肾亏虚,致脾肾阳虚,命门火衰,使气血不利,目络瘀阻而致。这一过程是一个以虚为本,因虚致瘀,最终发展为虚中夹瘀的缓慢病理过程。在此认识的基础上,导师丁淑华教授根据自己多年临床经验,针对其发病机理,以补益肝肾、益气活血、化瘀通络为法,自拟单味中药浓缩颗粒配方夜明颗粒治疗RP。
临床上观察夜明颗粒治疗RP患者,对治疗后患者视力、视敏度、闪光视网膜电图进行分析,所得临床资料表明夜明颗粒在治疗RP和减缓病情发展方面有一定的疗效,各项指标均有不同程度的改善,有效率达84.5%。
前期的动物实验是通过观察、分析夜明颗粒不同剂量对小鼠微循环、清除体内自由基、调节免疫,对大鼠血液流变学影响等7个实验的结果来探讨夜明颗粒制剂治疗RP的机理。实验数据表明夜明颗粒可以改善微循环,降低血黏度,具有活血化瘀作用;改善小鼠血液SOD活性,降低MDA值,增强小鼠清除体内自由基和积存的脂质过氧化物的能力;对免疫功能有调节作用。
为了进一步探讨夜明颗粒制剂对RP的疗效机制,我们通过观察rds小鼠视网膜光感受器细胞的病理变化来探讨夜明颗粒对遗传性视网膜色素变性小鼠可能的治疗作用。取4周龄、12周龄、24周龄rds鼠各9只,都随机分为三组,夜明颗粒组4只、杞菊地黄丸组3只和对照组2只。给药28d后取眼球,立即经10%中性甲醛固定,光学显微镜下观察水平视网膜近赤道部位光感受器细胞的厚度。经夜明颗粒治疗后,光镜结果显示,rds小鼠光感受器细胞层数、细胞数明显增加及光感受器细胞凋亡率的下降(P＜0.05)。实验的结果表明夜明颗粒可延缓rds小鼠视网膜感受器细胞的破坏。
Retinitis pigmentosa(RP) is a hereditary retinal degenerative disease. This paper researches treating the RP with "Yeming grain" from three aspects which are the theory studying,the clinical research and the empirical study, as well as explores the possible mechanism of the qi and kidney tonics and blood-activating and stasis-removing drugs "Yeming grain" treating the RP.
The morbility of the RP possesses genetic predisposition. The cause is inherent deficiency,deficiency of the liver and kidney,which results in asdthenic splenonephro-yang,decline of vital gate-fire,qi and blood disorder,eye collaterals stagnation. This is a slow-moving patho- process which is based on void, then results in stagnation,and develops to void nipping stagnation at last. My tutor Shuhua Ding invents the prescription of "Yeming grain" to treat the RP according to her clinical experience. This prescription aims directly at the etiopathogenesis of the RP,and establishes the principle of removing stagnation and filling void.
The clinical observation of the patient who is treated by "Yeming grain" and the analyses of eyesight, visual acuity,and bright-flash electroretinogram indicate that "Yeming grain" is effective."Yeming grain" can not only relieve the progression of disease but improve each index. The effective rate is 84.5%.
In the first text,we give the treatment to rats,then observe and analyze the effect of different dosages on the microcirculation,cleaning up the free radicle in vivo,accommodating the immunity and the rat's hemorheology.Results:"Yeming grain" can improve the microcirculation,step down the blood viscosity, promote blood flow and remove stagnation;it can improve the SOD activity of rat's blood,step down the value of MDA,and enhance the cat's capability of cleaning up the free radicle in vivo and the accumulation of lipid peroxidate;it also have accommodative effect on the immune function.
To go deep into exploring the mechanism of "Yeming grain" treating the RP and to determine whether tetram ethylpyrazine hydrochlorde has an efficacy on hereditary retinitis pigmentosa of rds mice by the observation of the photo receptor cells. Nine rds mice of 4 week old were randomly divided into three groups, "Yeming grain" group(4 mice),"qujudihuangwan" group(3 mice) and control group(2 mice).All mice were sacrificed after 28d with eyes being immediately enucleated and fixed in 10% form aldehyde in PBS. Routine pathologic process was done and sections were stained by hematoxylin and eosin(HE).The layer numbers of retinal photo receptor cells at equator posterior center was counted under light micro scopy. Nine rds mice of 12week old did as so on.
Result from light microscopy showed that the layer numbers and numbers of retinal photo receptor cells in the tetram ethylpyrazine treatment group were increased in rds mice,compared with the control group(P<0.05).
Conclusion from light microscopy and electron microscope suggest that tetram ethylpyrazine has a significant efficacy to the retinal photo receptor cells of rds mice.
引文
[1]曾庆华.中医眼科学.北京:中国中医药出版社,2003,212
[2]唐由之,王明芳,陆南山,等.中国医学百科全书·中医眼科学,上海:上海科学技术出版社,1985,68
[3]李传课.新编中医眼科学.北京:人民军医出版社,1995,229
[4]古继红,喻干龙,朱有章.视网膜色素变性辨证分型与血管内皮血小板功能改变关系的初步研究.中国中医眼科杂志,2000,10(2):81
[5]李万山.中西医结合治疗视网膜色素变性的疗效观察.实用眼科杂志,1994,2(1):61
[6]彭清华.视网膜色素变性血瘀机理研究.江苏中医,1999,(1):39
[7]吴星伟,唐由之.中医药治疗视网膜色素变性的PVEP研究.眼科研究,1996,14(4):260-263
[8]唐由之,肖国士.中医眼科学全书[M].北京:人民卫生出版,2000
[9]王永炎,庄曾渊.今日中医眼科[M].北京:人民卫生出版社,2000
[10]徐又芳.中医五官科名著集成[M].北京:华夏出版社,1997
[11]杨永升等.对古文献中关于治疗夜盲方剂的研究.中国中医眼科杂志2007.17(1).54-56
[12]刘怀栋,张彬,魏素英.庞赞襄中医眼科经验.石家庄:河北科学技术出版社,1994,154-157
[13]陆绵绵.中西医结合治疗眼病.北京:人民卫生出版社,1982,307
[14]Baumgartner WA.Etiology,pathogenesis,and experimental treatment of retinitis pigmentosa[J].Med Hypoyheses,2000,54(5):814-824.
[15]Wang Q,Chen Q,Zhao K,et al.Update on the molecular genetics of retinitis pigmentosa[J].Ophthalmic Genet,2001,22(3):133-154.
[16]蒋沁,曹国凡,胡红莉.视网膜色素变性的研究进展.眼视光学杂志,2006,126-130.
[17]Hardie RC.Nature,2001,186
[18]Wolfrum U.Cell Motil Cytoskeleton,2000.95
[19]Humphries P,Kenna P,Farrar G.On the molecular genetics of retinitis pigmentosa[J].Hum Mol Genet,2002,11(10):804-808.
[20]Nathans J,Hogness DS.Isolation and nucleotide sequence of the gene encoding human rhodop sin.Proc Nat Acad Sci USA,1984,81:4851-4855.
[21]RetNet http://www.sph.uth.tmc.edu/RetNet/
[22]Retina International http://www.retina international.com/
[23]Briscoe AD,Gaur C,Kumar S.The spectrum of human rhodop sin disease mutations through the lens of interspecific variation.Gene,2004,12:107-118.
[24]ChanWM,Yeung KY,Pang CP,et al.Rhodop sin mutations in Chinese patientswith autosomal dominant retinitis p igmentosa.Br J Ophthalmol,2001,85:1046-1048.
[25]Rosenfeld PJ,Cowley GS,McGee TL,et al.A nullmutation in the rhodop sin gene causes rod photorecep tor dysfunction and autosomal recessive retinitis pigmentosa.Nat Genet,1992,1:209-213.
[26]BayesM,Martinez Mir A,Valverde D,et al.Autosomal recessive retinitis pigmentosa in Spain:evaluation of four genes and two lociinvolved in the disease.Clin Genet,1996,50:380-387.
[27]Pierce EA,Quinn T,Meehan T,et al.Mutations in a gene encoding a new oxygen regulated photorecep tor protein cause dominant retinitis pigmentosa.Nat Genet,1999,22:248-254.
[28]Liu Q,Zuo J,Pierce EA.The retinitis p igmentosa is a photorecep tormicro tubuleassociation protein.J Neurosci,2004,24:6427-6436.
[29]Sullivan LS,Heckenlively JR,Bowne SJ,et al.Mutations in a novel retina specific gene cause autosomal dominant retinitis pigmentosa.Nat Genet,1999,2:255-259.
[30]Baum L,ChanWM,Yeung KY,et aI.RP1 in Chinese:Eight novel variants and evidence that truncation of the extreme C2terminal does not cause retinitis p igmentosa.Hum Mutat,2001,17:436-439.
[31]Kawamura M,Wada Y,Noda Y,et al.Novel 2336-2337
[32]Capeans C,BlancoMJ,LareuMV,et al.Linkage analysis in a large Spanish family with X-linked retinitis pigmentosa:phenotype genotype correlation,lin Genet,1991,54:26-32.
[33]Meindl A,Dry K,Herrmann K,et al.A gene(RPGR) with homology to the RCC1 Guanine nucleotide exchange factor ismutated in X-linked retinitis pigmentosa(RP3).Nat Genet,1996,13:35-42.
[34]Vervoot R,Lennon A,Bird AC,et al.Mutation hot spot within a new RPGR exon in X-linked retinitis pigmentosa.Nat Genet,2000,25:462-466.
[35]Bader I,Brandau O,AchatzH,et al.X-linked retinitis pigmentosa:RPGR mutations in most families with definite X linkage and clustering of mutations in a short sequence stretch of exon ORF15.Invest Ophthalmol Vis Sci,2003,44:1458-1463.
[36]Liu L,J in L,Liu M,et al.Identification of two novel mutations(332X and c153delC)in the RPGR gene in two Chinese families with X-linked retinitis pigmentosa.Hum Mutat,2000,15:584.
[37]SohochiMM,Daiger SP,Bowne SJ,et al.Prevalence of mutations causing reitnitis pigmentosa and other inherited retinopathies.Hum Mut,2001,17:42-51.
[38]Gal A.Nat Genet,2000.270
[39]Van Soest S.Surv Ophthalinol,1999,43(4):321
[40]Btustedt MS.Invest Ophthalmol Vis Sci,1999.995
[41]Morimura H.Pros Natl Acad Sci USA,1998.3088
[42]Snn H.Nat Genet,1997.15
[43]Morimura H.Nat Genet,1999.393
[44]Vithana EN.Mol Cell,2001.375
[45]Fei Y.Invest Ophthalmol Vis Sci,2000.2849
[46]Mitton KP.Biol Chem,2000.29794
[47]王丹艺,范宝剑,巫向前,陈伟民,林顺潮,彭智培.视网膜色素变性的分子遗传学研究进展与基因治疗.中华眼科杂志.2005,41(2):188-192
[48]刘斌.遗传性视网膜变性与视细胞调亡.眼科研究,1998,16:2
[49]彭清华.女绝经期后视网膜色素变性患者的血清性激素改变冲西医结合眼科杂志,1995,13:7
[50]古继红.视网膜色素变性患者血管内皮-血小板功能变化.中西医结合眼科杂志,1996,14:65
[51]易细香,李传课,余杨桂.视网膜色素变性不同证型红细胞免疫功能及T淋巴细胞表面抗原表达的改变.广州中医药大学学报,2004,21(3):188-190
[52]冯俊,庄曾渊,李庆生,等.补肾明目药对原发性视网膜色素变性患者血清超氧化物歧化酶活性的影响.中国中医基础医学杂志,1997,3(4):36
[53]张承芬.眼底病学.北京:人民卫生出版社,1998.400
[54]高卫萍,丁淑华,章淑华.视网膜色素变性患者视觉电生理观察.临床眼科杂志,2000,(12):411-412
[55]Alexandridis E,krastel H.眼科电生理诊断学.北京:人民卫生出版社,1991.3-10
[56]Dolan FM,Parks S,Hammer H,et al.The wide field multifocal electrorerinogram reveals retinal dysfunction in early retinitis pigmentosa[J].British Journal of Ophthalmology,2002,86(4):480
[57]Sutter EE.Lateral interaction component and local luminance nonlinearities in the human pattern reversal ERG.Vision Res,1990,30:659-671.
[58]张伟,赵堪兴,崔石.散发型视网膜色素变性患者的多焦视网膜电图检查.中华眼底病杂志,2002,18(2):153-154
[59]吴德正,江福钿,梁炯基,等.视网膜色素变性的多焦视网膜电图特征[J].眼科研究,2000,18(4):346-349
[60]Seeliger M,Kretschmanu U,Aptelsted-Sylla E,et al.ultifocalelectroretinography in retinitis pigmentosa[J].Am J Ophthalmol,1998,125:214-226
[61]董枫,杨顺海,郑海华.视网膜色素变性患者多焦视网膜电图特征.中国中医眼科杂志2005,15(3):132-134
[62]李海生,潘家普.视觉电生理的原理与实践[M].上海:上海科学普及出版社;2002:293,247.
[63]Hood D C,Seiple W,Greenstein V C,et al.A comparison of the com2ponents of the multifocal and full-field ERGs[J].Vis Neurosci,1997,14:533-544
[64]吴乐正,吴德正,主编.临床视觉电生理学[M].北京:科学出版社,1999.14-26
[65]丁琦,严良,陆豪,杨蕾,秦洁,赵婕,熊毅.mrERG在原发性视网膜色素变性病程中应用研究.眼科新进展,2006;26(10):778-779
[66]唐松,黄丽娜,张国明,罗恒,曾键.视网膜色素变性患者的多焦视网膜电图与视网膜光学相干断层扫描的观察分析.临床眼科杂志,2006,14(6):
[67]吴乐正,吴德正.临床视觉电生理学.北京:科学出版社,1999,103-113.
[68]吴德正,江福钿,梁炯基,等.视网膜色素变性的多焦视网膜电图.眼科研究,2000;18(4):346-349.
[69]Seeliger M,Kretschmann N,Aptelsted-Sylla E,et al.Multifocal electroretinography in retinitis pigmentosa.AmJ Ophthalmol,1998;125(2):214-226.
[70]Klistorner AI,Graham SL,Grigg JR,et al.Multifocaltopographic visual evoked potential improving objectivedetection of local visual field defects.Invest Ophthalmol Vis Sci,1998;39(6):937-950.
[71]Goldberg I,Graham SL,Klistomer AI.Multifocalobjective perimetry in the detection of glaucomatous fieldloss.Am J Ophthalmol,2002;133(1):29-39.
[72]Klistomer AI,Graham SL.Objective perimetry inglaucoma.Ophthalmology,2000;107(12):2283-2299.
[73]龙时先,江福钿,吴德正,梁炯基.视网膜色素变性的多焦视诱发电位及其与视野的比较.眼科学报.2006,22:76-79.
[74]Chan A,Duker JS,Ishikawa H,et al.Quantification of photoreceptor layer thickness in normal eyes using op tical coherence tomography.Retina,2006,26:655-660.
[75]Guedes V,Schuman JS,Hertzmark E,et al.Optical coherence tomographymeasurement ofmacular and nerve fiber layer thickness in normal and glaucomatous human eyes.Ophthalmology,2003,110:177-189.
[76]黄丽娜,主编.光学相干断层成像术的临床应用.广州:新世纪出版社,2002,9-17.
[77]朱有章,谢立科,朱春光,等.对中医综合治疗视网膜色素变性患者眼底荧光血管造影改变的观察,中国中医眼科杂志1995,5(2)95-97
[78]Jarc-vidmar M,Hawtina M.Abnormal fundus autofluorescence in relation to retinal function in patients with retinitis pigmentosa.ophthalmology,2006,2(3):37-38(视网膜色素变性患者眼底异常自发荧光与视网膜功能的关系 世界核心医学期刊·眼科学,2006,2(3):37-38)
[79]丁淑华,倪云,高卫萍,等.视网膜色素变性患者血液流变学的观察.临床眼科杂志,1999,7(1):5-6
[80]Oh KT,Longmuir R,Oh DM,et al.Comparison of the clinical expression of retinitis pigmentosa associated with rhodop sin mutations at codon 347 and codon 23.Am J Ophthalmol,2003,136:306-313.
[81]Bowne SJ,Daiger SP,HimsMM,et al.Mutations in the RP1 gene causing autosomal dominant retinitis pigmentosa.Hum Mol Genet,1999,8:2121-2128.
[82]Steinmetz LM,Mindrinos M,Oefner PJ.Combining genome sequences and new technologies for dissecting the genetics of comp lex phenotypes.Trends Plant Sci,2000,5:397-401.
[83]Kwok PY,Chen X.Detection of single nucleotide polymorphisms.Curr IssuesMol Biol,2003,5:43-60.
[84]Lem J,Krasnoperova NV,Calvert PD,et al.Morphological physiological and biochemical changes in rhodopsin knockout mice[J].Proc Nat.Acad Sci U S A,1999,96(2):736-741
[85]Humphries MM,Rancourt D,Farrar GJ.Retinopathy induced in mice by targeted disruption of the rhodopsin gene[J].Nat Genet,1997,15(2):216-219.
[86]Steinberg RH,Flannery JG,Naash M,et al.Transgenic rat models of inherited retinal degeneration caused by mutant opsin genes[J].Invest Ophthalmol Vis Sci,1996,37:S6981
[87]Farrar GJ,Kenna P,Jordan SA.A three base pair deletion in the peripherin RDS gene in one form of retinitis pigmentosa[J].Nature,1991,354(6353):478-480
[88]Cayouette M,Behn D,Sendtner M.Intraocular gene transfer of ciliary neurotrophic factor prevents death and increases responsiveness of rod photoreceptors in the retinal degeneration slow mouse[J].J Neurosci,1998,18(22):9282-9293.
[89]Sanyal S,De Ruiter A,Hawkins RK.Development and degeneration of retina in rds mutant mice:light microscopy[J].J Comp Neurol,1980,194(1):193-207.
[90]Petters RM,Alexander CA,Wells KD.Genetically engineered large animal model for studying cone photoreceptor survival and degeneration in retinitis pigmentosa[J].Nat Biotechnol,1997,15(10):965-970.
[91]Bowes C,Li T,Danciger M.Retinal degeneration in the rd mouse is caused by a defect in the beta subunit of rod cGMP-phosphodiesterase[J].Nature,1990,347(6294):677-680.
[92]Carter-Dawson LD,LaVail MM,Sidman RL.Differential effect of the rd mutation on rods and cones in the mouse retina[J].Invest Ophthalmol Vis Sci,1978,17(6):489-498.
[93]Morimura H,Fishman GA,Grover SA.Mutations in the RPE65 gene in patients with autosomal recessive retinitis pigmentosa or leber congenital amaurosis[J].Proc Natl Acad Sci U S A,1998,95(6):3088-3093
[94]Hagstrom SA,North MA,Nishina PL.Recessive mutations in the gene encoding the tubby2like protein TULP1 in patients with retinitis pigmentosa[J].Nat Genet,1998,18(2):174-176.
[95]LaVail MM,Sidman RL,Gerhardt CO.Congenic strains of RCS rats with inherited retinal dystrophy[J].J Hered,1975,66(4):242-244.
[96]Narfstrom K,Nilsson SE.Hereditary rod2cone degeneration in a strain of Abyssinian cats[J].Prog Clin Biol Res,1987,247:349-368.
[97]Suber ML,Pittler SJ,Qin N.Irish setter dogs affected with rodPcone dysplasia contain a nonsense mutation in the rod cGMP phosphodiesterase beta2subunit gene[J].Proc Natl Acad Sci U S A,1993,90(9):3968-3972.
[98]Barbehenn E,Gagnon C,Noelker D.Inherited rod2cone dysplasia:abnormal distribution of cyclic GMP in visual cells of affected Irish setters[J].Exp Eye Res,1988,46(2):149-159.
[99]Aguirre GD,Baldwin V,Pearce2Kelling S.Congenital stationary night blindness in the dog:common mutation in the RPE65 gene indicates founder effect[J].Molecular Vision,1998,4:231
[100]Hong DH,Pawlyk BS,Shang J.A retinitis pigmentosa GTPase regulator(RPGR)2deficient mouse model for X2linked retinitis pigmentosa(RP3)[J].Proc Natl Acad Sci U S A,2000,97(7):3649-3654.
[101]Acland GM,Blanton SH,Hershfield B.XLPRA:a canine retinal degeneration inherited as an X-linked trait[J].Am J Med Genet,1994,52(1):27-33.
[102]余涛,阴正勤.视网膜变性疾病的动物模型研究进展.中国比较医学杂志.2005,15(2):120-123
[103]梁丽娜,李根林,王津津,等.中药对体外培养视网膜神经细胞的干预作用研究[J].眼科新进展,2004,24(6):422-425
[104]高卫平,丁淑华,朱萱萱,曹国凡.夜明颗粒对小鼠微循环和大鼠血黏度影响实验研究.南京中医药大学学报,2005,21(3):166-167
[105]梁丽娜.李根林,王津津,庄曾渊.中药复方制剂对rds小鼠感光细胞凋亡的干预作用研究.Chin Ophthal Res,October 2005,Vol.23,No.5:462-464
[106]邓新国,胡世兴,贾小芸,张清炯,罗琳.川芎嗪对rd和rds小鼠视网膜色素变性的光感受器细胞干预作用的光镜观察.中草药,2006,37(6):891-894
[107]邓新国,张清炯,胡世兴,陈金卯,李岱,林少春.川芎嗪对视网膜色素变性rd小鼠的干预作用及其抗凋亡作用机制研究.中国中医眼科杂志,2006,16(3):148-152
[108]鹿道直,崔小庆,林平.灵素丸治疗视网膜色素变性疗效观察.中国中医眼科杂志,1994,4(4):201-202
[109]丁淑华,高卫萍,朱宣宣,等.夜明颗粒治疗视网膜色素变性的临床及实验研究.南京中医药大学学报,2000,16(4):206-208
[110]邓海先,邓想民,邓想淑,等.雀目夜明丸治疗视网膜色素变性36例[J].中医研究,2002,15(4):37-39
[111]冯俊,庄增渊,李庆生,等.补肾明目药对原发性视网膜色素变性患者血清超氧化物歧化酶活性的影响.中国中医基础医学杂志,1997,3(4):36
[112]李传课,彭清华,曾明葵,等.益气明目丸治疗脾胃气虚型视神经萎缩和视网膜色素变性疗效观察.中国中医眼科杂志,1997,7(1):14
[113]李传课,李波,彭清华,等.滋阴明目丸治疗肝肾阴虚视网膜色素变性与老年黄斑变性的临床观察.湖南中医学院学报.2001,21(3):38-39
[114]汪国智,丁淑华.夜明颗粒治疗视网膜色素变性52例.实用中医药杂志2006,22(12):768-769
[115]倪云,丁淑华.针灸治疗视网膜色素变性疗效观察.长春中医学院学报,2000,16(3):5
[116]张惠,郎福文.针药并用治疗视网膜色素变性13例.实用中医药杂志,2000,16(10):8
[117]仙石满.视网膜色素变性的中医学治疗.国外医学·中医中药分册,1993,15(2):26
[118]周胜红,裴利红,张俊华.针刺治疗111例家系视网膜色素变性临床观察.山东中医药大学学报,2003,27(3):201
[119]王松荣.针灸治疗视网膜色素变性临床研究冲西医结合眼科,1992,(1):11
[120]罗明,针刺加穴位注射治疗视网膜色素变性31例.中国针灸,2003,23(2):102
[121]窦惠芳,张鸥,叶增桂,等.针刺治疗原发性视网膜色素变性临床观察.中国针灸,1996,(10):13-14
[122]刘坚,张仁.电针治疗原发性视网膜色素变性65例.中国针灸,2000,(10):595
[123]王桂红,郝小波,彭崇信,等.定量视野检查对麝香注射液穴位注射治疗视网膜色素变性疗效的评价.新中医,2002,34(2):48
[124]白鹏,王影,赵吉平,孙河,包大鹏等.电针与单纯针刺治疗视网膜色素变性的临床对比研究.针灸临床杂志,2006,22(9):17-19
[125]陈祖铿.视网膜色素变性的中医治疗.新中医,1997,29(7):36
[126]张惠,朗福东.针药并用治疗视网膜色素变性13例.实用中医药杂志,2000,16(10):8-9
[127]王静,朱宁云,石磊.针药并用治疗视网膜色素变性临床体会.中国中医药信息杂志,2005,12(3):57
[128]韩光,韩文东.视网膜色素变性的中医治疗.吉林中医药,2006,26(10)
[129]李种泰,针灸穴位注射合中药治疗视网膜色素变性29例.陕西中医2006,27(4):447-448
[130]曾巍.明目地黄汤合丹参注射液治疗视网膜色素变性临床观察.湖北中医杂志,1997,19(2):22
[131]姜健丽,曾红艳.灯盏花素注射粉剂合色变一号方治疗原发性视网膜色素变性疗效观察.中国中医药科技,2005,12(5):318-319
[132]Blomer U,Naldini L,Verma IM,et al.Applications of gene therapy to the CNS[J].Hum Mol Genet,1996,5:1397-1404.
[133]尹连荣,孙慧敏,袁佳琴.视网膜色素变性的遗传学及治疗学研究进展.国外医学眼科学分册,2004,28(2):116-118期
[134]Kaufman PL et al.Surv Ophthalmol,1999;43 Suppl1:591
[135]Abraham NG et al.Invest Ophthalmol Vis Sci,1995;36:2202
[136]Reichel MB et al.Gene Ther,1998;5(8):1038
[137]Reichel MB et al.Br J Ophthalmol,2001;85(3):255
[138]Bennett Jet al.Invest Ophthalmol Vis Sci,1994;35:2535
[139]Dreyer EB et al.Neuroreport,1999;10(14):2887
[140]Guy J et al.Arch Ophathalmol,1999;117(7):929
[141]Takahashi Met al.J Virol,1999;73(9):7812
[142]Miyoshi H et al.Proc Natl Acad Sci USA,1997;94(19):10319
[143]Chaum E et al.J Cell Biochem,1999;76(1):153
[144]Neglia F et al.Cancer Gene,1999;6(4):349
[145]LascauOComan V et al.AmJ Pathol,1999;154(4):1159
[146]Sanchez GI et al.Infect Immun,2001;69(6):3897
[147]AbulOHassan K et al.Curr Eye Res,2000;20(5):361
[148]Bochot A et al.J Drug Target,1998;6(4):309
[149]Toy J et al.J Neurosci Methods,2000;104(1):1
[150]Ali RR,Reichel MB,Hunt DM,et al.Gene therapy for inherited retinal degeneration[J].Br J Ophthalmol,1997,81(9):795-801.
[151]Taimai M.Electrophysiological study in juvenile retinoschisis[J].Nippon Ganka Zasshi,1996,100(12):983-987.
[152]鲍玉洲,郭希让.视网膜色素变性新疗法的评估.国外医学眼科学分册.2002,26(1):18-22
[153]庞宝华,唐晨.人视网膜移植研究进展.医学综述,2006,12(17):1055-1058
[154]Woch G,Aramant RB,Seiler MJ,et al.Retinal transplants restore visually evoked responses in rats with photoreceptor degeneration[J].Invest Ophthalmol Vis Sci,2001,42(7):1669-1676.
[155]Radner W et al.Invest Ophthalmol Vis Sci,2001;42(5):1057
[156]Sheng Y et al.Invest Ophthalmol Vis Sci,1995;36:381
[157]Del Cerro M,Humayun MS,Sadda SR,et al.Histologic correlation of human neural retinal transplantation[J].Invest Ophthalmol Vis Sci,2000,41(10):3142-3148.
[158]Radtke ND,Aramant RB,Seiler M,et al.Preliminary report:indications of improved visual funtion after retinal sheet transplantation in retinitis pigmentosa patients[J].Am J Ophthalmol,1999,128(3):384-387.
[159]Berger AS,Tezel TH,Del Priora LV,et al.Photoreceptor transplantation in retinitis pigmentosa:shortterm follow up[J].Ophthalmology,2003,110(2):383-391.
[160]Radtke ND,Aramant RB,Seiler MJ,et al.Vision chang after sheet transplant of Fetal Retinal with Retinal Pigment Epithelium to a patient with Retinitis Pigmentosa[J].Arch Ophthalmol,2004,122(8):1159-1165.
[161]Das T,Del Cerro M,Jalali S,et al.The of human fetal neuroretinal cells in advanced retinitis pigmentosa patients:result of a longterm safty study[J].Exp Neurol,1999,157(1):58-68.
[162]Lin N et al.Curr Eye Res,1996;15(10):1069
[163]Young MJ,Ray J,Whiteley SJ,et al.Neuronal differentiation and morphological integration of hippocampal progenitor cells transplanted to the retina of immature and mature dystrophic rats[J].Mol Cell Neurosci,2000,16(3):197-205.
[164]Chacko DM,Rogers JA,Turner JE,et al.Survival and differentiation of cultured retinal progenitors transplanted in the subretinal space of the rat[J].Biochem Biophys Res Commun,2000,268(3):842.
[165]Hui YN,Wang JB,Wang L.Recent advances in research of retinal prosthesis[J].Rec Adv Ophthalmol,2003,23(2):73-75.
[166]Chow AY,Chow VY,Packo KH,et al.The artificial silicon retina microchip for the treatment of vision loss from retinitis pigmentosa[J].Arch Ophthalmol,2004,122(2):460-469.
[167]郑浩,李根林.细胞因子对视网膜神经元保护和诱导作用的研究进展.中华眼科杂志,2005,41(9):861-864
[168]Lau D,McGee LH,Zhou S,et al.Retinal degeneration is slowed in transgenic rats by AAV-mediated delivery of FGF-2.Invest Ophthalmol Vis Sci,2000,41:3622-3633
[169]Borhani H,Peyman GA,Rahimy MH,et al.Vitreoretinal toxicity of basic fibroblast growth factor[J].Int Ophthalmol,1993,17(4):195-199.
[170]Lavail MM,Yasumura D,Matthes MT,et al.Protection of mouse photoreceptors by survival factors in retinal degenerations[J].Invest Ophthalmol Vis Sci,1998,39(3):592-602.
[171]Caffe AR,Soderpalm AK,Holmqvist I,et al.A combination of CNTF and BDNF rescues rd photoreceptors but changes rod differentiation in the presence of RPE in retinal explants.Invest Ophthalmol Vis Sci,2001,42:275-282
[172]邱晓荣,刘庆淮,谢平.睫状神经营养因子对视网膜色素变性RD小鼠治疗作用的研究.南京医科大学学报.2006,26(5):310-312
[173]Frasson M,Picaud S,Leveillard T,et al.Glial cell line2derived neurotrophic factor induces histologic and functional protection of rod photoreceptors in the rd/rd mouse[J].Invest Ophthalmol Vis Sci,1999,40(11):2724-2734.
[174]Ahuja P,Caffe AR,Holmqvist I,et al.Lens epithelium-derived growth factor(LEDGF) delays photoreceptor degeneration in explants of rd/rd mouse retinal Neuroreport,2001,12:2951-2955
[175]Lapp in T.The cellular biology of erythropoietin receptors.Oncologist,2003;8:15-18
[176]Chong ZZ,Lin SH,Kang JQ et al.Erythropoietin prevents early and late neuronal demise through modulation of Akt1 and induction of caspase 1,3and8.J Neurosci Res,2003;71:659-669
[177]Brines ML,Ghezzi P,Keenan S et al.Erythropoietin cross the blood-brain barrier to protect against experimental brain injury.Proc Natl Acad Sci USA,2000;97:10526-10531
[178]VairanoM,Dello Russo C,Pozzoli G et al.Erythropoietin exerts antiapoptotic effects on rat microglial cells in vitro.Eur J Neurosci,2002;16:584-592
[179]乔淑红,迟焕芳.促红细胞生成素对视网膜色素变性的RCS大鼠的作用.神经解剖学杂志.2006,22(2):163-168(Chinese Journal of Neuroanatomy)
[180]Das I,Sparrow J R,Lin MI,Shih E,Micawa T,Hempsted BL.Trk C signaling is required for retinal progenitor cell proliferation[J].J Neurosci 2000;20(8):2887-2895.
[181]Bennett JL,Zeiler SR,Jones KR.Patterned expression of BDNF and NT-3 in the retina and anterior segment of the developing mammalian eye[J].Invest Ophthalmol Vis Sci 1999;40(12):2996-3005.
[182]郑浩,李根林,刘月月.正常和色素变性视网膜组织内神经营养素-3表达的变化月艮科新进展.2006,26(6):408-412
[183]Maw MA,Kennedy B,Knight A,et al.Mutation of the gene encoding cellular retinal dehyde-binding protein in autosomal recessive retinitis pigmentosa[J].Nat Genet,1997,17(2):198-200.
[184]Berson El,Rosner B,Sandberg MA,et al.A randomized trial of vitamin A and vitaminE supplementation for retinitis pigmentosa[J].Arch ophthalmol,1993,111(6):761-172.
[185]Dratz EA,Starkey JR,Starkey JR,et al.NMR constrained solution structrues for lamin in peptide Ⅱ.Analogs define structural requirements for inhibition of tumor cell invasion of basement membrance matrix[J].J Biol Chem,1992,267(35):122-127.
[186]Gibson NJ,Brown MF.Membrane lipid influences on the energetics of the metarhodopsin Ⅰ and metarhodopsin Ⅱ conformational states of rhodopsin probed by flash photolysis[J].Photochem Photobiol,1991,54(6):985-592.
[187]Slater SJ,Ho C,Taddeo FJ,et al.Contribution of hydrogen bonding to lipid-lipid interactions in membranes and the role of lipid order:effects of cholesterol,increased phospholipid unsaturation,and ethanol[J].Biochemistry,1993,32(14):3714-3721.
[188]Wetzel MG,Fahlman C,O'Brien PJ,et al.Metabolic labeling of rod outer segment phospholipids in miniature poodles with progressive rod-cone degeneration(prcd)[J].Exp Eye Res,1990,50(1):89-97.
[189]Hackos DH,Korenbrot J I,et al.Divalent cation selectivity is a function of gating in native and recombinant cyclic nucleotide2gated on channels from retinal photoreceptors[J].J Gen Physiol,1999,113(6):799-818.
[190]Medrano CJ,Fox DA.Oxygen consumption in the rat outer and inner retina:light and pharmacologically induced inhibition[J].Exp Eye Res,1995,61(3):273-284.
[191]Unoki Ketal.Invest Ophthalmol Vis Sci,1994;35:907
[192]Cayouette Metal.Hum Gene Ther,1997;8:423
[193]田培坤等.中国科学(C辑),1998;28(6):554
[194]Uteza Y et al.Proc Natl Acad Sci USA,1999;96(6):3126
[195]孙承录,齐景福,孙海东.眼肌脉络膜贴附术治疗原发性视网膜色素变性.天津医药,1997,25(9):547-549
[196]蔡浩然,杨春华,庞秀洁.视网膜色素变性眼肌深层巩膜移植术患者图形视觉诱发电位分析.国际眼科杂志,2003,3(4):35-37
[197]谢立科,朱有章;朱春光,等.中西医结合治疗视网膜色素变性30例临床观察.中国中医药科技,1996,3(4):37-38
[198]谢立科,杨永升,庄曾渊,接传红,胡世兴.中西医结合眼科学的新进展.中国中医眼科杂志,2007,17(1):58-61
[199]蔡松年.中西医结合眼科学的回顾和展望[J].中国中医眼科杂志,2005,15(4):211-215
[200]吴星伟,唐由之冲医药治疗视网膜色素变性的定量视野学研究.中国医药学报,1997,12(3):17
[201]顾豪.中西医治合治疗视网膜色素变性.四川中医,1997,15(1):53
[202]谢静华,殷丽旭,侯占鹏.中西医结舍治疗视网膜色素变性38例疗效观察.吉林中医药,2001(6):40
[203]龙云生,刘岩.中医综合疗法治疗视网膜色素变性的疗效观察.天津中医,1999,16(4):16
[204]孙艳,相晓军,宁英慧,樊晓娟.中西医结合治疗视网膜色素变性临床观察.实用医技杂志2006,13(10):1758-1759
[205]彭清华,胡欣平,曾自明.视网膜色素变性辨证论治与血清性激素关系的初步研究.中国中医眼科杂志,1993,3(2):80
[206]罗旭昇,庄曾渊.视网膜色素变性患者视网膜血流状态的共焦激光扫描多普勒血流仪分析.中国中医眼科杂志,2002,12(1):7
[207]谢立科,张明亮,彭清华等.从眼底荧光血管造影看视网膜色素变瘀性的血瘀机理.辽宁中医杂志,1995,22(9):392
[208]江晓芬,朱文锋,李传课.视网膜色素变性的球结膜微循环观察月艮科学报,1994,10(4):217
[209]李更生,于震,王慧森.地黄化学成分与药理研究进展.国外医学中医中药分册,2004,26(2):74-78
[210]地黄药理研究近况(管家齐、郭艳丽、吴海良、张名伟),中药材第24卷第5期2001年5月:380-382
[211]王金童,王秀娟.枸杞子的化学成分和药理研究概况.天津药学,1999,11(3):14-16
[212]陈庆伟,陈志桃.枸杞多糖药理作用研究进展.海峡药学,2005,17(4):4-7
[213]张敏,赵太济,张新华,郭长强.枸杞子抗衰老保肝等实验研究综述.时珍国医国药,2000,11(4):373-375
[214]楚晋,李林.山萸肉化学成分及其药理活性的研究.中国自然医学杂志,1999,1(1):46-48
[215]杨晓丽,王立为.中药何首乌的药理作用研究进展.中医药信息,2004,21(6):12-13
[216]刘汉珍,刘爱荣,李孝良等.白芍的化学成分及药理研究进展.安徽技术师范学院学报,2001,15(4):54-57
[217]姜建萍.白芍的现代药理研究及临床应用概况.中医药信息,2003,(3):6-8
[218]周强,栗占国.白芍总苷的药理作用及其在自身免疫性疾病中的应用.中国新药与临床杂 志,2003,22(11):687-689
[219]王朝虹,闵知大.芍药化学成分及药理研究.时珍国医国药,1999,10(7):544-546
[220]云秦川.中药黄芪的药理研究进展.内蒙古中医药,2004(6):33-34
[221]何正光,徐晓玉.黄芪对血管保护作用的药理研究进展.中国药房,2006,16(20):1589-1590
[222]刘玉莲,杨丛忠.黄芪药理作用概述.中国药业,2004,13(10):79
[223]秦葵,钱彦丛.灵芝免疫药理研究进展.解放军药学学报,2003,19(5):360-362
[224]刘建萍,刘雪平.灵芝免疫活性成分及其制剂的研究概况.天津药学,2004,16(6):43-45
[225]刘经亮.灵芝多糖的药理研究进展.广东药学,2000,10(2):46-48
[226]郝瑞芳,李荣春.灵芝多糖的药理和保健作用及应用前景.食用菌学报2004,11(4):57-62
[227]彭招华,袁吕明,韩民利.丹参的药理作用研究概况.中药材,2001,24(9):691-693
[228]陈丽娜,朱晓新.丹参改善血液流变性的实验研究进展.中国中药杂志,2005,30(8):630-633
[229]张丽琼,崔浩.丹参在眼科的应用.中国中医眼利杂志,2005,15(4):242-244
[230]冯俊志.赵国平.当归的免疫药理研究进展.福建中医药,2003,34(3):49-51
[231]张翠兰,文德鉴.当归对血液及造血系统药理作用研究进展.湖北民族学院学报·医学版,2002,19(4):34
[232]MaJ,Norton J C,A llen A C,et al.Retinal degeneration slow(rds) in mouse results from simple insertion of athap lotype-specific element into protein-coding exon Ⅱ[J].Genomics,1995,28:212-219
[233]SagaM,Mashima Y,Akeo K,et al.A novel homozygous Ile535A sn mutation in the rod cGMP phosphodiesterase betasubunit gene in two brothers of a Japanese family with autosomal recessive retinitis pigmentosa[J].Curr Eye R es,1998,17(3):332-335.
[234]Keen T J,Inglehearn C F.Mutations and polymorphisms in the human peripherin-RDS gene and their involvement in inherited retinal egeneration[J].Hum Mutat,1996,8:297-303.
[235]Luthert P J,Chong N H.Photoreceptor rescue[J].Eye,1998,12:591-596.
[236]Delyfer M N,Leveillard T,Mohand-Said S,et al.Inherited retinal degeneration in the rds/rds mouse[J].Neuro-report,2001,12(5):1011-1014.
[237]Chen J,Flannery J G,Lavail M M,et al.Bcl-2 overexpression reduces apoptotic photoreceptou cell death in three different retinal degeneration[J].Pro Natl Acad Sci USA,1996,93:7047-7048.
[2]唐由之,王明芳,陆南山,等.中国医学百科全书·中医眼科学,上海:上海科学技术出版社,1985,68
[3]李传课.新编中医眼科学.北京:人民军医出版社,1995,229
[4]古继红,喻干龙,朱有章.视网膜色素变性辨证分型与血管内皮血小板功能改变关系的初步研究.中国中医眼科杂志,2000,10(2):81
[5]李万山.中西医结合治疗视网膜色素变性的疗效观察.实用眼科杂志,1994,2(1):61
[6]彭清华.视网膜色素变性血瘀机理研究.江苏中医,1999,(1):39
[7]吴星伟,唐由之.中医药治疗视网膜色素变性的PVEP研究.眼科研究,1996,14(4):260-263
[8]唐由之,肖国士.中医眼科学全书[M].北京:人民卫生出版,2000
[9]王永炎,庄曾渊.今日中医眼科[M].北京:人民卫生出版社,2000
[10]徐又芳.中医五官科名著集成[M].北京:华夏出版社,1997
[11]杨永升等.对古文献中关于治疗夜盲方剂的研究.中国中医眼科杂志2007.17(1).54-56
[12]刘怀栋,张彬,魏素英.庞赞襄中医眼科经验.石家庄:河北科学技术出版社,1994,154-157
[13]陆绵绵.中西医结合治疗眼病.北京:人民卫生出版社,1982,307
[14]Baumgartner WA.Etiology,pathogenesis,and experimental treatment of retinitis pigmentosa[J].Med Hypoyheses,2000,54(5):814-824.
[15]Wang Q,Chen Q,Zhao K,et al.Update on the molecular genetics of retinitis pigmentosa[J].Ophthalmic Genet,2001,22(3):133-154.
[16]蒋沁,曹国凡,胡红莉.视网膜色素变性的研究进展.眼视光学杂志,2006,126-130.
[17]Hardie RC.Nature,2001,186
[18]Wolfrum U.Cell Motil Cytoskeleton,2000.95
[19]Humphries P,Kenna P,Farrar G.On the molecular genetics of retinitis pigmentosa[J].Hum Mol Genet,2002,11(10):804-808.
[20]Nathans J,Hogness DS.Isolation and nucleotide sequence of the gene encoding human rhodop sin.Proc Nat Acad Sci USA,1984,81:4851-4855.
[21]RetNet http://www.sph.uth.tmc.edu/RetNet/
[22]Retina International http://www.retina international.com/
[23]Briscoe AD,Gaur C,Kumar S.The spectrum of human rhodop sin disease mutations through the lens of interspecific variation.Gene,2004,12:107-118.
[24]ChanWM,Yeung KY,Pang CP,et al.Rhodop sin mutations in Chinese patientswith autosomal dominant retinitis p igmentosa.Br J Ophthalmol,2001,85:1046-1048.
[25]Rosenfeld PJ,Cowley GS,McGee TL,et al.A nullmutation in the rhodop sin gene causes rod photorecep tor dysfunction and autosomal recessive retinitis pigmentosa.Nat Genet,1992,1:209-213.
[26]BayesM,Martinez Mir A,Valverde D,et al.Autosomal recessive retinitis pigmentosa in Spain:evaluation of four genes and two lociinvolved in the disease.Clin Genet,1996,50:380-387.
[27]Pierce EA,Quinn T,Meehan T,et al.Mutations in a gene encoding a new oxygen regulated photorecep tor protein cause dominant retinitis pigmentosa.Nat Genet,1999,22:248-254.
[28]Liu Q,Zuo J,Pierce EA.The retinitis p igmentosa is a photorecep tormicro tubuleassociation protein.J Neurosci,2004,24:6427-6436.
[29]Sullivan LS,Heckenlively JR,Bowne SJ,et al.Mutations in a novel retina specific gene cause autosomal dominant retinitis pigmentosa.Nat Genet,1999,2:255-259.
[30]Baum L,ChanWM,Yeung KY,et aI.RP1 in Chinese:Eight novel variants and evidence that truncation of the extreme C2terminal does not cause retinitis p igmentosa.Hum Mutat,2001,17:436-439.
[31]Kawamura M,Wada Y,Noda Y,et al.Novel 2336-2337
[32]Capeans C,BlancoMJ,LareuMV,et al.Linkage analysis in a large Spanish family with X-linked retinitis pigmentosa:phenotype genotype correlation,lin Genet,1991,54:26-32.
[33]Meindl A,Dry K,Herrmann K,et al.A gene(RPGR) with homology to the RCC1 Guanine nucleotide exchange factor ismutated in X-linked retinitis pigmentosa(RP3).Nat Genet,1996,13:35-42.
[34]Vervoot R,Lennon A,Bird AC,et al.Mutation hot spot within a new RPGR exon in X-linked retinitis pigmentosa.Nat Genet,2000,25:462-466.
[35]Bader I,Brandau O,AchatzH,et al.X-linked retinitis pigmentosa:RPGR mutations in most families with definite X linkage and clustering of mutations in a short sequence stretch of exon ORF15.Invest Ophthalmol Vis Sci,2003,44:1458-1463.
[36]Liu L,J in L,Liu M,et al.Identification of two novel mutations(332X and c153delC)in the RPGR gene in two Chinese families with X-linked retinitis pigmentosa.Hum Mutat,2000,15:584.
[37]SohochiMM,Daiger SP,Bowne SJ,et al.Prevalence of mutations causing reitnitis pigmentosa and other inherited retinopathies.Hum Mut,2001,17:42-51.
[38]Gal A.Nat Genet,2000.270
[39]Van Soest S.Surv Ophthalinol,1999,43(4):321
[40]Btustedt MS.Invest Ophthalmol Vis Sci,1999.995
[41]Morimura H.Pros Natl Acad Sci USA,1998.3088
[42]Snn H.Nat Genet,1997.15
[43]Morimura H.Nat Genet,1999.393
[44]Vithana EN.Mol Cell,2001.375
[45]Fei Y.Invest Ophthalmol Vis Sci,2000.2849
[46]Mitton KP.Biol Chem,2000.29794
[47]王丹艺,范宝剑,巫向前,陈伟民,林顺潮,彭智培.视网膜色素变性的分子遗传学研究进展与基因治疗.中华眼科杂志.2005,41(2):188-192
[48]刘斌.遗传性视网膜变性与视细胞调亡.眼科研究,1998,16:2
[49]彭清华.女绝经期后视网膜色素变性患者的血清性激素改变冲西医结合眼科杂志,1995,13:7
[50]古继红.视网膜色素变性患者血管内皮-血小板功能变化.中西医结合眼科杂志,1996,14:65
[51]易细香,李传课,余杨桂.视网膜色素变性不同证型红细胞免疫功能及T淋巴细胞表面抗原表达的改变.广州中医药大学学报,2004,21(3):188-190
[52]冯俊,庄曾渊,李庆生,等.补肾明目药对原发性视网膜色素变性患者血清超氧化物歧化酶活性的影响.中国中医基础医学杂志,1997,3(4):36
[53]张承芬.眼底病学.北京:人民卫生出版社,1998.400
[54]高卫萍,丁淑华,章淑华.视网膜色素变性患者视觉电生理观察.临床眼科杂志,2000,(12):411-412
[55]Alexandridis E,krastel H.眼科电生理诊断学.北京:人民卫生出版社,1991.3-10
[56]Dolan FM,Parks S,Hammer H,et al.The wide field multifocal electrorerinogram reveals retinal dysfunction in early retinitis pigmentosa[J].British Journal of Ophthalmology,2002,86(4):480
[57]Sutter EE.Lateral interaction component and local luminance nonlinearities in the human pattern reversal ERG.Vision Res,1990,30:659-671.
[58]张伟,赵堪兴,崔石.散发型视网膜色素变性患者的多焦视网膜电图检查.中华眼底病杂志,2002,18(2):153-154
[59]吴德正,江福钿,梁炯基,等.视网膜色素变性的多焦视网膜电图特征[J].眼科研究,2000,18(4):346-349
[60]Seeliger M,Kretschmanu U,Aptelsted-Sylla E,et al.ultifocalelectroretinography in retinitis pigmentosa[J].Am J Ophthalmol,1998,125:214-226
[61]董枫,杨顺海,郑海华.视网膜色素变性患者多焦视网膜电图特征.中国中医眼科杂志2005,15(3):132-134
[62]李海生,潘家普.视觉电生理的原理与实践[M].上海:上海科学普及出版社;2002:293,247.
[63]Hood D C,Seiple W,Greenstein V C,et al.A comparison of the com2ponents of the multifocal and full-field ERGs[J].Vis Neurosci,1997,14:533-544
[64]吴乐正,吴德正,主编.临床视觉电生理学[M].北京:科学出版社,1999.14-26
[65]丁琦,严良,陆豪,杨蕾,秦洁,赵婕,熊毅.mrERG在原发性视网膜色素变性病程中应用研究.眼科新进展,2006;26(10):778-779
[66]唐松,黄丽娜,张国明,罗恒,曾键.视网膜色素变性患者的多焦视网膜电图与视网膜光学相干断层扫描的观察分析.临床眼科杂志,2006,14(6):
[67]吴乐正,吴德正.临床视觉电生理学.北京:科学出版社,1999,103-113.
[68]吴德正,江福钿,梁炯基,等.视网膜色素变性的多焦视网膜电图.眼科研究,2000;18(4):346-349.
[69]Seeliger M,Kretschmann N,Aptelsted-Sylla E,et al.Multifocal electroretinography in retinitis pigmentosa.AmJ Ophthalmol,1998;125(2):214-226.
[70]Klistorner AI,Graham SL,Grigg JR,et al.Multifocaltopographic visual evoked potential improving objectivedetection of local visual field defects.Invest Ophthalmol Vis Sci,1998;39(6):937-950.
[71]Goldberg I,Graham SL,Klistomer AI.Multifocalobjective perimetry in the detection of glaucomatous fieldloss.Am J Ophthalmol,2002;133(1):29-39.
[72]Klistomer AI,Graham SL.Objective perimetry inglaucoma.Ophthalmology,2000;107(12):2283-2299.
[73]龙时先,江福钿,吴德正,梁炯基.视网膜色素变性的多焦视诱发电位及其与视野的比较.眼科学报.2006,22:76-79.
[74]Chan A,Duker JS,Ishikawa H,et al.Quantification of photoreceptor layer thickness in normal eyes using op tical coherence tomography.Retina,2006,26:655-660.
[75]Guedes V,Schuman JS,Hertzmark E,et al.Optical coherence tomographymeasurement ofmacular and nerve fiber layer thickness in normal and glaucomatous human eyes.Ophthalmology,2003,110:177-189.
[76]黄丽娜,主编.光学相干断层成像术的临床应用.广州:新世纪出版社,2002,9-17.
[77]朱有章,谢立科,朱春光,等.对中医综合治疗视网膜色素变性患者眼底荧光血管造影改变的观察,中国中医眼科杂志1995,5(2)95-97
[78]Jarc-vidmar M,Hawtina M.Abnormal fundus autofluorescence in relation to retinal function in patients with retinitis pigmentosa.ophthalmology,2006,2(3):37-38(视网膜色素变性患者眼底异常自发荧光与视网膜功能的关系 世界核心医学期刊·眼科学,2006,2(3):37-38)
[79]丁淑华,倪云,高卫萍,等.视网膜色素变性患者血液流变学的观察.临床眼科杂志,1999,7(1):5-6
[80]Oh KT,Longmuir R,Oh DM,et al.Comparison of the clinical expression of retinitis pigmentosa associated with rhodop sin mutations at codon 347 and codon 23.Am J Ophthalmol,2003,136:306-313.
[81]Bowne SJ,Daiger SP,HimsMM,et al.Mutations in the RP1 gene causing autosomal dominant retinitis pigmentosa.Hum Mol Genet,1999,8:2121-2128.
[82]Steinmetz LM,Mindrinos M,Oefner PJ.Combining genome sequences and new technologies for dissecting the genetics of comp lex phenotypes.Trends Plant Sci,2000,5:397-401.
[83]Kwok PY,Chen X.Detection of single nucleotide polymorphisms.Curr IssuesMol Biol,2003,5:43-60.
[84]Lem J,Krasnoperova NV,Calvert PD,et al.Morphological physiological and biochemical changes in rhodopsin knockout mice[J].Proc Nat.Acad Sci U S A,1999,96(2):736-741
[85]Humphries MM,Rancourt D,Farrar GJ.Retinopathy induced in mice by targeted disruption of the rhodopsin gene[J].Nat Genet,1997,15(2):216-219.
[86]Steinberg RH,Flannery JG,Naash M,et al.Transgenic rat models of inherited retinal degeneration caused by mutant opsin genes[J].Invest Ophthalmol Vis Sci,1996,37:S6981
[87]Farrar GJ,Kenna P,Jordan SA.A three base pair deletion in the peripherin RDS gene in one form of retinitis pigmentosa[J].Nature,1991,354(6353):478-480
[88]Cayouette M,Behn D,Sendtner M.Intraocular gene transfer of ciliary neurotrophic factor prevents death and increases responsiveness of rod photoreceptors in the retinal degeneration slow mouse[J].J Neurosci,1998,18(22):9282-9293.
[89]Sanyal S,De Ruiter A,Hawkins RK.Development and degeneration of retina in rds mutant mice:light microscopy[J].J Comp Neurol,1980,194(1):193-207.
[90]Petters RM,Alexander CA,Wells KD.Genetically engineered large animal model for studying cone photoreceptor survival and degeneration in retinitis pigmentosa[J].Nat Biotechnol,1997,15(10):965-970.
[91]Bowes C,Li T,Danciger M.Retinal degeneration in the rd mouse is caused by a defect in the beta subunit of rod cGMP-phosphodiesterase[J].Nature,1990,347(6294):677-680.
[92]Carter-Dawson LD,LaVail MM,Sidman RL.Differential effect of the rd mutation on rods and cones in the mouse retina[J].Invest Ophthalmol Vis Sci,1978,17(6):489-498.
[93]Morimura H,Fishman GA,Grover SA.Mutations in the RPE65 gene in patients with autosomal recessive retinitis pigmentosa or leber congenital amaurosis[J].Proc Natl Acad Sci U S A,1998,95(6):3088-3093
[94]Hagstrom SA,North MA,Nishina PL.Recessive mutations in the gene encoding the tubby2like protein TULP1 in patients with retinitis pigmentosa[J].Nat Genet,1998,18(2):174-176.
[95]LaVail MM,Sidman RL,Gerhardt CO.Congenic strains of RCS rats with inherited retinal dystrophy[J].J Hered,1975,66(4):242-244.
[96]Narfstrom K,Nilsson SE.Hereditary rod2cone degeneration in a strain of Abyssinian cats[J].Prog Clin Biol Res,1987,247:349-368.
[97]Suber ML,Pittler SJ,Qin N.Irish setter dogs affected with rodPcone dysplasia contain a nonsense mutation in the rod cGMP phosphodiesterase beta2subunit gene[J].Proc Natl Acad Sci U S A,1993,90(9):3968-3972.
[98]Barbehenn E,Gagnon C,Noelker D.Inherited rod2cone dysplasia:abnormal distribution of cyclic GMP in visual cells of affected Irish setters[J].Exp Eye Res,1988,46(2):149-159.
[99]Aguirre GD,Baldwin V,Pearce2Kelling S.Congenital stationary night blindness in the dog:common mutation in the RPE65 gene indicates founder effect[J].Molecular Vision,1998,4:231
[100]Hong DH,Pawlyk BS,Shang J.A retinitis pigmentosa GTPase regulator(RPGR)2deficient mouse model for X2linked retinitis pigmentosa(RP3)[J].Proc Natl Acad Sci U S A,2000,97(7):3649-3654.
[101]Acland GM,Blanton SH,Hershfield B.XLPRA:a canine retinal degeneration inherited as an X-linked trait[J].Am J Med Genet,1994,52(1):27-33.
[102]余涛,阴正勤.视网膜变性疾病的动物模型研究进展.中国比较医学杂志.2005,15(2):120-123
[103]梁丽娜,李根林,王津津,等.中药对体外培养视网膜神经细胞的干预作用研究[J].眼科新进展,2004,24(6):422-425
[104]高卫平,丁淑华,朱萱萱,曹国凡.夜明颗粒对小鼠微循环和大鼠血黏度影响实验研究.南京中医药大学学报,2005,21(3):166-167
[105]梁丽娜.李根林,王津津,庄曾渊.中药复方制剂对rds小鼠感光细胞凋亡的干预作用研究.Chin Ophthal Res,October 2005,Vol.23,No.5:462-464
[106]邓新国,胡世兴,贾小芸,张清炯,罗琳.川芎嗪对rd和rds小鼠视网膜色素变性的光感受器细胞干预作用的光镜观察.中草药,2006,37(6):891-894
[107]邓新国,张清炯,胡世兴,陈金卯,李岱,林少春.川芎嗪对视网膜色素变性rd小鼠的干预作用及其抗凋亡作用机制研究.中国中医眼科杂志,2006,16(3):148-152
[108]鹿道直,崔小庆,林平.灵素丸治疗视网膜色素变性疗效观察.中国中医眼科杂志,1994,4(4):201-202
[109]丁淑华,高卫萍,朱宣宣,等.夜明颗粒治疗视网膜色素变性的临床及实验研究.南京中医药大学学报,2000,16(4):206-208
[110]邓海先,邓想民,邓想淑,等.雀目夜明丸治疗视网膜色素变性36例[J].中医研究,2002,15(4):37-39
[111]冯俊,庄增渊,李庆生,等.补肾明目药对原发性视网膜色素变性患者血清超氧化物歧化酶活性的影响.中国中医基础医学杂志,1997,3(4):36
[112]李传课,彭清华,曾明葵,等.益气明目丸治疗脾胃气虚型视神经萎缩和视网膜色素变性疗效观察.中国中医眼科杂志,1997,7(1):14
[113]李传课,李波,彭清华,等.滋阴明目丸治疗肝肾阴虚视网膜色素变性与老年黄斑变性的临床观察.湖南中医学院学报.2001,21(3):38-39
[114]汪国智,丁淑华.夜明颗粒治疗视网膜色素变性52例.实用中医药杂志2006,22(12):768-769
[115]倪云,丁淑华.针灸治疗视网膜色素变性疗效观察.长春中医学院学报,2000,16(3):5
[116]张惠,郎福文.针药并用治疗视网膜色素变性13例.实用中医药杂志,2000,16(10):8
[117]仙石满.视网膜色素变性的中医学治疗.国外医学·中医中药分册,1993,15(2):26
[118]周胜红,裴利红,张俊华.针刺治疗111例家系视网膜色素变性临床观察.山东中医药大学学报,2003,27(3):201
[119]王松荣.针灸治疗视网膜色素变性临床研究冲西医结合眼科,1992,(1):11
[120]罗明,针刺加穴位注射治疗视网膜色素变性31例.中国针灸,2003,23(2):102
[121]窦惠芳,张鸥,叶增桂,等.针刺治疗原发性视网膜色素变性临床观察.中国针灸,1996,(10):13-14
[122]刘坚,张仁.电针治疗原发性视网膜色素变性65例.中国针灸,2000,(10):595
[123]王桂红,郝小波,彭崇信,等.定量视野检查对麝香注射液穴位注射治疗视网膜色素变性疗效的评价.新中医,2002,34(2):48
[124]白鹏,王影,赵吉平,孙河,包大鹏等.电针与单纯针刺治疗视网膜色素变性的临床对比研究.针灸临床杂志,2006,22(9):17-19
[125]陈祖铿.视网膜色素变性的中医治疗.新中医,1997,29(7):36
[126]张惠,朗福东.针药并用治疗视网膜色素变性13例.实用中医药杂志,2000,16(10):8-9
[127]王静,朱宁云,石磊.针药并用治疗视网膜色素变性临床体会.中国中医药信息杂志,2005,12(3):57
[128]韩光,韩文东.视网膜色素变性的中医治疗.吉林中医药,2006,26(10)
[129]李种泰,针灸穴位注射合中药治疗视网膜色素变性29例.陕西中医2006,27(4):447-448
[130]曾巍.明目地黄汤合丹参注射液治疗视网膜色素变性临床观察.湖北中医杂志,1997,19(2):22
[131]姜健丽,曾红艳.灯盏花素注射粉剂合色变一号方治疗原发性视网膜色素变性疗效观察.中国中医药科技,2005,12(5):318-319
[132]Blomer U,Naldini L,Verma IM,et al.Applications of gene therapy to the CNS[J].Hum Mol Genet,1996,5:1397-1404.
[133]尹连荣,孙慧敏,袁佳琴.视网膜色素变性的遗传学及治疗学研究进展.国外医学眼科学分册,2004,28(2):116-118期
[134]Kaufman PL et al.Surv Ophthalmol,1999;43 Suppl1:591
[135]Abraham NG et al.Invest Ophthalmol Vis Sci,1995;36:2202
[136]Reichel MB et al.Gene Ther,1998;5(8):1038
[137]Reichel MB et al.Br J Ophthalmol,2001;85(3):255
[138]Bennett Jet al.Invest Ophthalmol Vis Sci,1994;35:2535
[139]Dreyer EB et al.Neuroreport,1999;10(14):2887
[140]Guy J et al.Arch Ophathalmol,1999;117(7):929
[141]Takahashi Met al.J Virol,1999;73(9):7812
[142]Miyoshi H et al.Proc Natl Acad Sci USA,1997;94(19):10319
[143]Chaum E et al.J Cell Biochem,1999;76(1):153
[144]Neglia F et al.Cancer Gene,1999;6(4):349
[145]LascauOComan V et al.AmJ Pathol,1999;154(4):1159
[146]Sanchez GI et al.Infect Immun,2001;69(6):3897
[147]AbulOHassan K et al.Curr Eye Res,2000;20(5):361
[148]Bochot A et al.J Drug Target,1998;6(4):309
[149]Toy J et al.J Neurosci Methods,2000;104(1):1
[150]Ali RR,Reichel MB,Hunt DM,et al.Gene therapy for inherited retinal degeneration[J].Br J Ophthalmol,1997,81(9):795-801.
[151]Taimai M.Electrophysiological study in juvenile retinoschisis[J].Nippon Ganka Zasshi,1996,100(12):983-987.
[152]鲍玉洲,郭希让.视网膜色素变性新疗法的评估.国外医学眼科学分册.2002,26(1):18-22
[153]庞宝华,唐晨.人视网膜移植研究进展.医学综述,2006,12(17):1055-1058
[154]Woch G,Aramant RB,Seiler MJ,et al.Retinal transplants restore visually evoked responses in rats with photoreceptor degeneration[J].Invest Ophthalmol Vis Sci,2001,42(7):1669-1676.
[155]Radner W et al.Invest Ophthalmol Vis Sci,2001;42(5):1057
[156]Sheng Y et al.Invest Ophthalmol Vis Sci,1995;36:381
[157]Del Cerro M,Humayun MS,Sadda SR,et al.Histologic correlation of human neural retinal transplantation[J].Invest Ophthalmol Vis Sci,2000,41(10):3142-3148.
[158]Radtke ND,Aramant RB,Seiler M,et al.Preliminary report:indications of improved visual funtion after retinal sheet transplantation in retinitis pigmentosa patients[J].Am J Ophthalmol,1999,128(3):384-387.
[159]Berger AS,Tezel TH,Del Priora LV,et al.Photoreceptor transplantation in retinitis pigmentosa:shortterm follow up[J].Ophthalmology,2003,110(2):383-391.
[160]Radtke ND,Aramant RB,Seiler MJ,et al.Vision chang after sheet transplant of Fetal Retinal with Retinal Pigment Epithelium to a patient with Retinitis Pigmentosa[J].Arch Ophthalmol,2004,122(8):1159-1165.
[161]Das T,Del Cerro M,Jalali S,et al.The of human fetal neuroretinal cells in advanced retinitis pigmentosa patients:result of a longterm safty study[J].Exp Neurol,1999,157(1):58-68.
[162]Lin N et al.Curr Eye Res,1996;15(10):1069
[163]Young MJ,Ray J,Whiteley SJ,et al.Neuronal differentiation and morphological integration of hippocampal progenitor cells transplanted to the retina of immature and mature dystrophic rats[J].Mol Cell Neurosci,2000,16(3):197-205.
[164]Chacko DM,Rogers JA,Turner JE,et al.Survival and differentiation of cultured retinal progenitors transplanted in the subretinal space of the rat[J].Biochem Biophys Res Commun,2000,268(3):842.
[165]Hui YN,Wang JB,Wang L.Recent advances in research of retinal prosthesis[J].Rec Adv Ophthalmol,2003,23(2):73-75.
[166]Chow AY,Chow VY,Packo KH,et al.The artificial silicon retina microchip for the treatment of vision loss from retinitis pigmentosa[J].Arch Ophthalmol,2004,122(2):460-469.
[167]郑浩,李根林.细胞因子对视网膜神经元保护和诱导作用的研究进展.中华眼科杂志,2005,41(9):861-864
[168]Lau D,McGee LH,Zhou S,et al.Retinal degeneration is slowed in transgenic rats by AAV-mediated delivery of FGF-2.Invest Ophthalmol Vis Sci,2000,41:3622-3633
[169]Borhani H,Peyman GA,Rahimy MH,et al.Vitreoretinal toxicity of basic fibroblast growth factor[J].Int Ophthalmol,1993,17(4):195-199.
[170]Lavail MM,Yasumura D,Matthes MT,et al.Protection of mouse photoreceptors by survival factors in retinal degenerations[J].Invest Ophthalmol Vis Sci,1998,39(3):592-602.
[171]Caffe AR,Soderpalm AK,Holmqvist I,et al.A combination of CNTF and BDNF rescues rd photoreceptors but changes rod differentiation in the presence of RPE in retinal explants.Invest Ophthalmol Vis Sci,2001,42:275-282
[172]邱晓荣,刘庆淮,谢平.睫状神经营养因子对视网膜色素变性RD小鼠治疗作用的研究.南京医科大学学报.2006,26(5):310-312
[173]Frasson M,Picaud S,Leveillard T,et al.Glial cell line2derived neurotrophic factor induces histologic and functional protection of rod photoreceptors in the rd/rd mouse[J].Invest Ophthalmol Vis Sci,1999,40(11):2724-2734.
[174]Ahuja P,Caffe AR,Holmqvist I,et al.Lens epithelium-derived growth factor(LEDGF) delays photoreceptor degeneration in explants of rd/rd mouse retinal Neuroreport,2001,12:2951-2955
[175]Lapp in T.The cellular biology of erythropoietin receptors.Oncologist,2003;8:15-18
[176]Chong ZZ,Lin SH,Kang JQ et al.Erythropoietin prevents early and late neuronal demise through modulation of Akt1 and induction of caspase 1,3and8.J Neurosci Res,2003;71:659-669
[177]Brines ML,Ghezzi P,Keenan S et al.Erythropoietin cross the blood-brain barrier to protect against experimental brain injury.Proc Natl Acad Sci USA,2000;97:10526-10531
[178]VairanoM,Dello Russo C,Pozzoli G et al.Erythropoietin exerts antiapoptotic effects on rat microglial cells in vitro.Eur J Neurosci,2002;16:584-592
[179]乔淑红,迟焕芳.促红细胞生成素对视网膜色素变性的RCS大鼠的作用.神经解剖学杂志.2006,22(2):163-168(Chinese Journal of Neuroanatomy)
[180]Das I,Sparrow J R,Lin MI,Shih E,Micawa T,Hempsted BL.Trk C signaling is required for retinal progenitor cell proliferation[J].J Neurosci 2000;20(8):2887-2895.
[181]Bennett JL,Zeiler SR,Jones KR.Patterned expression of BDNF and NT-3 in the retina and anterior segment of the developing mammalian eye[J].Invest Ophthalmol Vis Sci 1999;40(12):2996-3005.
[182]郑浩,李根林,刘月月.正常和色素变性视网膜组织内神经营养素-3表达的变化月艮科新进展.2006,26(6):408-412
[183]Maw MA,Kennedy B,Knight A,et al.Mutation of the gene encoding cellular retinal dehyde-binding protein in autosomal recessive retinitis pigmentosa[J].Nat Genet,1997,17(2):198-200.
[184]Berson El,Rosner B,Sandberg MA,et al.A randomized trial of vitamin A and vitaminE supplementation for retinitis pigmentosa[J].Arch ophthalmol,1993,111(6):761-172.
[185]Dratz EA,Starkey JR,Starkey JR,et al.NMR constrained solution structrues for lamin in peptide Ⅱ.Analogs define structural requirements for inhibition of tumor cell invasion of basement membrance matrix[J].J Biol Chem,1992,267(35):122-127.
[186]Gibson NJ,Brown MF.Membrane lipid influences on the energetics of the metarhodopsin Ⅰ and metarhodopsin Ⅱ conformational states of rhodopsin probed by flash photolysis[J].Photochem Photobiol,1991,54(6):985-592.
[187]Slater SJ,Ho C,Taddeo FJ,et al.Contribution of hydrogen bonding to lipid-lipid interactions in membranes and the role of lipid order:effects of cholesterol,increased phospholipid unsaturation,and ethanol[J].Biochemistry,1993,32(14):3714-3721.
[188]Wetzel MG,Fahlman C,O'Brien PJ,et al.Metabolic labeling of rod outer segment phospholipids in miniature poodles with progressive rod-cone degeneration(prcd)[J].Exp Eye Res,1990,50(1):89-97.
[189]Hackos DH,Korenbrot J I,et al.Divalent cation selectivity is a function of gating in native and recombinant cyclic nucleotide2gated on channels from retinal photoreceptors[J].J Gen Physiol,1999,113(6):799-818.
[190]Medrano CJ,Fox DA.Oxygen consumption in the rat outer and inner retina:light and pharmacologically induced inhibition[J].Exp Eye Res,1995,61(3):273-284.
[191]Unoki Ketal.Invest Ophthalmol Vis Sci,1994;35:907
[192]Cayouette Metal.Hum Gene Ther,1997;8:423
[193]田培坤等.中国科学(C辑),1998;28(6):554
[194]Uteza Y et al.Proc Natl Acad Sci USA,1999;96(6):3126
[195]孙承录,齐景福,孙海东.眼肌脉络膜贴附术治疗原发性视网膜色素变性.天津医药,1997,25(9):547-549
[196]蔡浩然,杨春华,庞秀洁.视网膜色素变性眼肌深层巩膜移植术患者图形视觉诱发电位分析.国际眼科杂志,2003,3(4):35-37
[197]谢立科,朱有章;朱春光,等.中西医结合治疗视网膜色素变性30例临床观察.中国中医药科技,1996,3(4):37-38
[198]谢立科,杨永升,庄曾渊,接传红,胡世兴.中西医结合眼科学的新进展.中国中医眼科杂志,2007,17(1):58-61
[199]蔡松年.中西医结合眼科学的回顾和展望[J].中国中医眼科杂志,2005,15(4):211-215
[200]吴星伟,唐由之冲医药治疗视网膜色素变性的定量视野学研究.中国医药学报,1997,12(3):17
[201]顾豪.中西医治合治疗视网膜色素变性.四川中医,1997,15(1):53
[202]谢静华,殷丽旭,侯占鹏.中西医结舍治疗视网膜色素变性38例疗效观察.吉林中医药,2001(6):40
[203]龙云生,刘岩.中医综合疗法治疗视网膜色素变性的疗效观察.天津中医,1999,16(4):16
[204]孙艳,相晓军,宁英慧,樊晓娟.中西医结合治疗视网膜色素变性临床观察.实用医技杂志2006,13(10):1758-1759
[205]彭清华,胡欣平,曾自明.视网膜色素变性辨证论治与血清性激素关系的初步研究.中国中医眼科杂志,1993,3(2):80
[206]罗旭昇,庄曾渊.视网膜色素变性患者视网膜血流状态的共焦激光扫描多普勒血流仪分析.中国中医眼科杂志,2002,12(1):7
[207]谢立科,张明亮,彭清华等.从眼底荧光血管造影看视网膜色素变瘀性的血瘀机理.辽宁中医杂志,1995,22(9):392
[208]江晓芬,朱文锋,李传课.视网膜色素变性的球结膜微循环观察月艮科学报,1994,10(4):217
[209]李更生,于震,王慧森.地黄化学成分与药理研究进展.国外医学中医中药分册,2004,26(2):74-78
[210]地黄药理研究近况(管家齐、郭艳丽、吴海良、张名伟),中药材第24卷第5期2001年5月:380-382
[211]王金童,王秀娟.枸杞子的化学成分和药理研究概况.天津药学,1999,11(3):14-16
[212]陈庆伟,陈志桃.枸杞多糖药理作用研究进展.海峡药学,2005,17(4):4-7
[213]张敏,赵太济,张新华,郭长强.枸杞子抗衰老保肝等实验研究综述.时珍国医国药,2000,11(4):373-375
[214]楚晋,李林.山萸肉化学成分及其药理活性的研究.中国自然医学杂志,1999,1(1):46-48
[215]杨晓丽,王立为.中药何首乌的药理作用研究进展.中医药信息,2004,21(6):12-13
[216]刘汉珍,刘爱荣,李孝良等.白芍的化学成分及药理研究进展.安徽技术师范学院学报,2001,15(4):54-57
[217]姜建萍.白芍的现代药理研究及临床应用概况.中医药信息,2003,(3):6-8
[218]周强,栗占国.白芍总苷的药理作用及其在自身免疫性疾病中的应用.中国新药与临床杂 志,2003,22(11):687-689
[219]王朝虹,闵知大.芍药化学成分及药理研究.时珍国医国药,1999,10(7):544-546
[220]云秦川.中药黄芪的药理研究进展.内蒙古中医药,2004(6):33-34
[221]何正光,徐晓玉.黄芪对血管保护作用的药理研究进展.中国药房,2006,16(20):1589-1590
[222]刘玉莲,杨丛忠.黄芪药理作用概述.中国药业,2004,13(10):79
[223]秦葵,钱彦丛.灵芝免疫药理研究进展.解放军药学学报,2003,19(5):360-362
[224]刘建萍,刘雪平.灵芝免疫活性成分及其制剂的研究概况.天津药学,2004,16(6):43-45
[225]刘经亮.灵芝多糖的药理研究进展.广东药学,2000,10(2):46-48
[226]郝瑞芳,李荣春.灵芝多糖的药理和保健作用及应用前景.食用菌学报2004,11(4):57-62
[227]彭招华,袁吕明,韩民利.丹参的药理作用研究概况.中药材,2001,24(9):691-693
[228]陈丽娜,朱晓新.丹参改善血液流变性的实验研究进展.中国中药杂志,2005,30(8):630-633
[229]张丽琼,崔浩.丹参在眼科的应用.中国中医眼利杂志,2005,15(4):242-244
[230]冯俊志.赵国平.当归的免疫药理研究进展.福建中医药,2003,34(3):49-51
[231]张翠兰,文德鉴.当归对血液及造血系统药理作用研究进展.湖北民族学院学报·医学版,2002,19(4):34
[232]MaJ,Norton J C,A llen A C,et al.Retinal degeneration slow(rds) in mouse results from simple insertion of athap lotype-specific element into protein-coding exon Ⅱ[J].Genomics,1995,28:212-219
[233]SagaM,Mashima Y,Akeo K,et al.A novel homozygous Ile535A sn mutation in the rod cGMP phosphodiesterase betasubunit gene in two brothers of a Japanese family with autosomal recessive retinitis pigmentosa[J].Curr Eye R es,1998,17(3):332-335.
[234]Keen T J,Inglehearn C F.Mutations and polymorphisms in the human peripherin-RDS gene and their involvement in inherited retinal egeneration[J].Hum Mutat,1996,8:297-303.
[235]Luthert P J,Chong N H.Photoreceptor rescue[J].Eye,1998,12:591-596.
[236]Delyfer M N,Leveillard T,Mohand-Said S,et al.Inherited retinal degeneration in the rds/rds mouse[J].Neuro-report,2001,12(5):1011-1014.
[237]Chen J,Flannery J G,Lavail M M,et al.Bcl-2 overexpression reduces apoptotic photoreceptou cell death in three different retinal degeneration[J].Pro Natl Acad Sci USA,1996,93:7047-7048.